Sage Therapeutics Inc (SAGE)
11.89
-0.45
(-3.65%)
USD |
NASDAQ |
May 10, 16:00
11.89
0.00 (0.00%)
After-Hours: 19:39
Sage Therapeutics Total Assets (Quarterly): 767.60M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 767.60M |
| December 31, 2023 | 882.28M |
| September 30, 2023 | 949.66M |
| June 30, 2023 | 1.082B |
| March 31, 2023 | 1.221B |
| December 31, 2022 | 1.356B |
| September 30, 2022 | 1.486B |
| June 30, 2022 | 1.601B |
| March 31, 2022 | 1.706B |
| December 31, 2021 | 1.825B |
| September 30, 2021 | 1.927B |
| June 30, 2021 | 2.015B |
| March 31, 2021 | 2.081B |
| December 31, 2020 | 2.159B |
| September 30, 2020 | 738.63M |
| June 30, 2020 | 827.24M |
| March 31, 2020 | 944.97M |
| December 31, 2019 | 1.084B |
| September 30, 2019 | 1.204B |
| June 30, 2019 | 1.316B |
| March 31, 2019 | 1.423B |
| Date | Value |
|---|---|
| December 31, 2018 | 952.70M |
| September 30, 2018 | 1.047B |
| June 30, 2018 | 1.129B |
| March 31, 2018 | 1.101B |
| December 31, 2017 | 529.94M |
| September 30, 2017 | 251.08M |
| June 30, 2017 | 293.41M |
| March 31, 2017 | 351.17M |
| December 31, 2016 | 404.53M |
| September 30, 2016 | 436.30M |
| June 30, 2016 | 275.63M |
| March 31, 2016 | 303.51M |
| December 31, 2015 | 189.02M |
| September 30, 2015 | 208.41M |
| June 30, 2015 | 228.47M |
| March 31, 2015 | 115.48M |
| December 31, 2014 | 129.66M |
| September 30, 2014 | 137.96M |
| June 30, 2014 | 51.65M |
| March 31, 2014 | 56.78M |
| December 31, 2013 | 8.532M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
738.63M
Minimum
Sep 2020
2.159B
Maximum
Dec 2020
1.359B
Average
1.268B
Median
Total Assets (Quarterly) Benchmarks
| Biogen Inc | 26.57B |
| Perspective Therapeutics Inc | 97.89M |
| Vanda Pharmaceuticals Inc | 648.44M |
| Ligand Pharmaceuticals Inc | 913.87M |
| ADMA Biologics Inc | 329.18M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 61.80M |
| Shareholders Equity (Quarterly) | 705.80M |
| Current Ratio | 12.22 |